2115 | Humans |
1150 | Animals |
1124 | Coronavirus Infections |
891 | Middle East Respiratory Syndrome Coronavirus |
563 | Female |
562 | Male |
475 | Molecular Sequence Data |
441 | Base Sequence |
348 | Adult |
309 | Middle Aged |
292 | Disease Outbreaks |
279 | Mice |
274 | Amino Acid Sequence |
254 | Coronavirus |
248 | DNA |
240 | Sequence Analysis, DNA |
238 | Algorithms |
226 | Saudi Arabia |
223 | Aged |
204 | Protein Binding |
202 | Camelus |
190 | Antibodies, Viral |
188 | Models, Molecular |
176 | Antiviral Agents |
172 | Binding Sites |
171 | Spike Glycoprotein, Coronavirus |
168 | Cell Line |
162 | Phylogeny |
147 | Adolescent |
146 | Republic of Korea |
145 | Oligonucleotides |
142 | SARS Virus |
140 | Young Adult |
140 | Peptides |
134 | Software |
132 | Severe Acute Respiratory Syndrome |
128 | RNA, Viral |
127 | Nucleic Acid Conformation |
127 | Computational Biology |
127 | Antibodies, Neutralizing |
126 | Zoonoses |
122 | Kinetics |
119 | Escherichia coli |
117 | Oligodeoxyribonucleotides |
117 | Cross Infection |
116 | Viral Vaccines |
116 | Respiratory Tract Infections |
115 | Protein Conformation |
115 | Genome, Viral |
114 | Virus Replication |
112 | Middle East |
112 | Child |
109 | Travel |
104 | Communicable Diseases, Emerging |
101 | Sequence Alignment |
101 | Chiroptera |
98 | Disease Models, Animal |
97 | Aged, 80 and over |
95 | Viral Proteins |
94 | RNA, Messenger |
87 | Pneumonia, Viral |
86 | Thermodynamics |
86 | Mutation |
85 | Time Factors |
85 | Polymerase Chain Reaction |
85 | High-Throughput Nucleotide Sequencing |
85 | Dipeptidyl Peptidase 4 |
84 | Nucleic Acid Hybridization |
83 | RNA |
82 | Disease Reservoirs |
81 | Retrospective Studies |
80 | Recombinant Proteins |
80 | Child, Preschool |
79 | Antibodies, Monoclonal |
77 | Chlorocebus aethiops |
76 | Computer Simulation |
75 | Infection Control |
74 | Virus Internalization |
74 | Oligonucleotide Array Sequence Analysis |
74 | Lung |
74 | Epitopes |
73 | Structure-Activity Relationship |
73 | Real-Time Polymerase Chain Reaction |
72 | Mice, Inbred BALB C |
72 | Genomics |
72 | Cells, Cultured |
72 | Betacoronavirus |
71 | Risk Factors |
71 | Host-Pathogen Interactions |
71 | Evolution, Molecular |
70 | Vero Cells |
70 | Transcription Factors |
70 | China |
70 | Bacterial Proteins |
68 | Temperature |
67 | Receptors, Virus |
66 | Sensitivity and Specificity |
66 | Global Health |
66 | Enzyme-Linked Immunosorbent Assay |
65 | Pandemics |
65 | Immunoglobulin G |
65 | DNA Primers |
63 | Peptide Fragments |
63 | Circular Dichroism |
60 | Molecular Structure |
60 | Electrophoresis, Polyacrylamide Gel |
59 | DNA-Binding Proteins |
59 | DNA, Bacterial |
59 | Crystallography, X-Ray |
59 | Cluster Analysis |
58 | Reverse Transcriptase Polymerase Chain Reaction |
58 | Genome |
57 | Models, Genetic |
57 | Influenza, Human |
56 | Rats |
56 | Chromatography, High Pressure Liquid |
55 | Reproducibility of Results |
55 | Promoter Regions, Genetic |
53 | Protein Structure, Tertiary |
53 | Infant |
53 | Corpus Callosum |
52 | Transcription, Genetic |
52 | Substrate Specificity |
52 | Plasmids |
52 | Oligonucleotides, Antisense |
52 | Models, Chemical |
51 | Treatment Outcome |
50 | Hydrogen-Ion Concentration |
50 | Gene Expression |
49 | Health Personnel |
48 | Sequence Homology, Amino Acid |
48 | Protein Structure, Secondary |
48 | Genetic Variation |
48 | Cross-Sectional Studies |
48 | Cloning, Molecular |
47 | Cattle |
46 | Protein Multimerization |
46 | Molecular Weight |
46 | Magnetic Resonance Imaging |
46 | Genome, Human |
44 | Encephalitis |
44 | DNA Replication |
43 | T-Lymphocytes |
43 | Surveys and Questionnaires |
43 | DNA, Single-Stranded |
43 | Base Composition |
42 | Virus Diseases |
42 | Sequence Analysis, RNA |
42 | Public Health |
42 | Proteins |
42 | Prevalence |
42 | Metagenomics |
42 | HEK293 Cells |
41 | Species Specificity |
41 | Magnetic Resonance Spectroscopy |
41 | Gene Expression Profiling |
41 | Dimerization |
40 | Rabbits |
39 | United States |
39 | Models, Biological |
39 | Gene Expression Regulation |
38 | Protein Folding |
38 | Population Surveillance |
38 | Neutralization Tests |
38 | Disease Transmission, Infectious |
37 | Mice, Inbred C57BL |
37 | Databases, Genetic |
37 | Communicable Disease Control |
37 | Cell Line, Tumor |
36 | Viral Nonstructural Proteins |
36 | Models, Statistical |
36 | Mass Spectrometry |
36 | Epitope Mapping |
36 | DNA, Viral |
35 | World Health Organization |
35 | Seroepidemiologic Studies |
35 | Oligonucleotide Probes |
35 | HIV-1 |
34 | Viral Load |
34 | Ligands |
34 | Immunity, Innate |
34 | Genome, Bacterial |
34 | Cricetinae |
34 | Conserved Sequence |
33 | Syndrome |
33 | Signal Transduction |
33 | Cytokines |
33 | Brain Diseases |
32 | Vaccination |
32 | Mutagenesis, Site-Directed |
31 | Viruses |
31 | Tumor Cells, Cultured |
31 | Transfection |
31 | Epitopes, T-Lymphocyte |
31 | Drug Discovery |
31 | Drug Design |
31 | Binding, Competitive |
30 | Sequence Analysis, Protein |
30 | Peptide Library |
30 | Nucleic Acid Denaturation |
30 | Molecular Conformation |
30 | In Vitro Techniques |
30 | Cell Membrane |
30 | Blotting, Western |
30 | Bacteria |
29 | Risk Assessment |
29 | Macromolecular Substances |
29 | HeLa Cells |
29 | Epidemics |
29 | Coronaviridae |
29 | Brain |
28 | Viral Envelope Proteins |
28 | Sequence Homology, Nucleic Acid |
28 | Protein Biosynthesis |
28 | Nucleotide Motifs |
28 | Genetic Vectors |
28 | Dose-Response Relationship, Drug |
27 | Spectrometry, Mass, Electrospray Ionization |
27 | Repetitive Sequences, Nucleic Acid |
27 | Recombination, Genetic |
27 | Protein Domains |
27 | Oligopeptides |
27 | Health Knowledge, Attitudes, Practice |
27 | Catalysis |
26 | Virus Shedding |
26 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
26 | Severity of Illness Index |
26 | Serine Endopeptidases |
26 | Regulatory Sequences, Nucleic Acid |
26 | Polymers |
26 | Genes, Viral |
26 | DNA Probes |
26 | Contact Tracing |
26 | Antigens, Viral |
25 | Water |
25 | Stereoisomerism |
25 | Solutions |
25 | Recombinant Fusion Proteins |
25 | Open Reading Frames |
25 | Molecular Diagnostic Techniques |
25 | Macaca mulatta |
25 | Infant, Newborn |
25 | Incidence |
25 | Immunohistochemistry |
25 | Hot Temperature |
25 | Cysteine Endopeptidases |
25 | Case-Control Studies |
25 | Alleles |
24 | United Arab Emirates |
24 | Saccharomyces cerevisiae |
24 | Respiratory System |
24 | RNA-Binding Proteins |
24 | Polymorphism, Single Nucleotide |
24 | Mice, Transgenic |
24 | Hospitals |
24 | Genotype |
24 | Escherichia coli Proteins |
23 | Prognosis |
23 | Peptide Hydrolases |
23 | Oligosaccharides |
23 | Models, Theoretical |
23 | Islam |
23 | Fluorescent Dyes |
23 | Fever |
23 | DNA, Complementary |
23 | DNA Adducts |
23 | Communicable Diseases |
23 | Cell Division |
23 | Amino Acid Motifs |
22 | Thionucleotides |
22 | Spectrophotometry, Ultraviolet |
22 | RNA, Small Interfering |
22 | Proteolysis |
22 | Protein Array Analysis |
22 | Prospective Studies |
22 | Nucleotides |
22 | Hemorrhagic Fever, Ebola |
22 | Epithelial Cells |
22 | Epidemiological Monitoring |
22 | DNA Damage |
22 | Biosensing Techniques |
22 | Base Pairing |
21 | Viral Tropism |
21 | Vaccines, Synthetic |
21 | Spectrometry, Fluorescence |
21 | Ribavirin |
21 | Protein Denaturation |
21 | Oxidation-Reduction |
21 | Nucleocapsid Proteins |
21 | Membrane Proteins |
21 | Influenza A virus |
21 | Indicators and Reagents |
21 | Immunization |
21 | Immunity, Cellular |
21 | Gene Library |
21 | Cross-Linking Reagents |
21 | CpG Islands |
21 | Coronaviridae Infections |
21 | Chromatography, Gel |
21 | Anti-Bacterial Agents |
20 | Tertiary Care Centers |
20 | Survival Analysis |
20 | Static Electricity |
20 | Receptors, Estrogen |
20 | Plant Proteins |
20 | Internet |
20 | Host Specificity |
20 | Drug Evaluation, Preclinical |
20 | Diagnosis, Differential |
20 | Cross Reactions |
20 | Amino Acids |
19 | Virus Attachment |
19 | Templates, Genetic |
19 | RNA, Bacterial |
19 | Microscopy, Electron |
19 | Metagenome |
19 | Interferons |
19 | History, 21st Century |
19 | Guanine |
19 | DNA Repair |
19 | Consensus Sequence |
19 | Cell Survival |
19 | CD4-Positive T-Lymphocytes |
19 | Bacillus subtilis |
19 | Adjuvants, Immunologic |
18 | Surface Properties |
18 | Protease Inhibitors |
18 | Peptide Nucleic Acids |
18 | Lymphocyte Activation |
18 | Immune Evasion |
18 | Estradiol |
18 | Deep Brain Stimulation |
18 | Databases, Protein |
18 | Comorbidity |
18 | Biopolymers |
18 | Apoptosis |
18 | Antibody Specificity |
17 | Virulence |
17 | Tomography, X-Ray Computed |
17 | Seasons |
17 | Protein Structure, Quaternary |
17 | Pregnancy |
17 | Nucleic Acid Heteroduplexes |
17 | Interferon-gamma |
17 | Interferon-alpha |
17 | Hydrogen Bonding |
17 | Drug Stability |
17 | Diffusion Magnetic Resonance Imaging |
17 | Cohort Studies |
17 | CD8-Positive T-Lymphocytes |
17 | Africa |
16 | Ultraviolet Rays |
16 | Subthalamic Nucleus |
16 | Sheep |
16 | Protein Processing, Post-Translational |
16 | Probability |
16 | Papain |
16 | Osmolar Concentration |
16 | Orthomyxoviridae |
16 | Organophosphorus Compounds |
16 | MicroRNAs |
16 | Liposomes |
16 | Light |
16 | Kidney |
16 | Genes, Reporter |
16 | Gene Expression Regulation, Viral |
16 | Feces |
16 | Exons |
16 | Enzyme Inhibitors |
16 | Enzyme Activation |
16 | Electrophoresis, Capillary |
16 | Databases, Nucleic Acid |
16 | DNA Methylation |
16 | Crystallization |
16 | Chromosome Mapping |
16 | Chromatin Immunoprecipitation |
16 | Catalytic Domain |
16 | Biomarkers |
16 | Bayes Theorem |
16 | Adenosine Triphosphate |
15 | Urea |
15 | Swine |
15 | Support Vector Machine |
15 | Staphylococcus aureus |
15 | Sodium Chloride |
15 | Sequence Analysis |
15 | Risk |
15 | RNA Replicase |
15 | Quarantine |
15 | Patient Isolation |
15 | Neurons |
15 | Microscopy, Atomic Force |
15 | Italy |
15 | Intensive Care Units |
15 | Immunoglobulin M |
15 | Hydrolysis |
15 | Horses |
15 | Ferritins |
15 | Europe |
15 | Estrogens |
15 | Electroencephalography |
15 | Chemical Phenomena |
15 | Cell Nucleus |
15 | Callithrix |
15 | Antigens, Bacterial |
15 | Antibodies |
15 | Amyloid beta-Peptides |
14 | Zika Virus Infection |
14 | Vaccines |
14 | Transcriptome |
14 | Spleen |
14 | Ribosomes |
14 | Radiography |
14 | Public Health Surveillance |
14 | Polyethylene Glycols |
14 | Phosphorylation |
14 | Pattern Recognition, Automated |
14 | Oligoribonucleotides |
14 | Mycobacterium tuberculosis |
14 | Macrophages |
14 | Introns |
14 | Interferon-beta |
14 | Inhibitory Concentration 50 |
14 | Hyaluronic Acid |
14 | Heat-Shock Proteins |
14 | Fatal Outcome |
14 | Epitopes, B-Lymphocyte |
14 | Enhancer Elements, Genetic |
14 | Ebolavirus |
14 | Drug Therapy, Combination |
14 | Deoxyguanosine |
14 | DNA-Directed RNA Polymerases |
14 | Chromosomes, Bacterial |
14 | Biomedical Research |
14 | Biological Evolution |
14 | Arabidopsis |
14 | Antigen Presentation |
14 | Amino Acid Substitution |
13 | Whole Genome Sequencing |
13 | T-Lymphocytes, Cytotoxic |
13 | Survival Rate |
13 | Sequence Homology |
13 | Rats, Sprague-Dawley |
13 | Random Amplified Polymorphic DNA Technique |
13 | Qatar |
13 | Protein Subunits |
13 | Protein Interaction Domains and Motifs |
13 | Pneumonia |
13 | Parkinson Disease |
13 | Nose |
13 | NF-kappa B |
13 | Microelectrodes |
13 | Mice, Knockout |
13 | Magnesium |
13 | Kenya |
13 | Hemocyanins |
13 | Gene Expression Regulation, Plant |
13 | Disease Progression |
13 | Chemistry, Physical |
13 | Bentonite |
13 | Artificial Intelligence |
12 | Ubiquitin |
12 | Solvents |
12 | Ribonuclease H |
12 | Restriction Mapping |
12 | Respiration, Artificial |
12 | Radiography, Thoracic |
12 | RNA, Ribosomal, 16S |
12 | Proteomics |
12 | Predictive Value of Tests |
12 | Polymorphism, Genetic |
12 | Point Mutation |
12 | Plasma |
12 | Phosphoric Diester Hydrolases |
12 | Phenotype |
12 | Oxygen |
12 | Odds Ratio |
12 | Nucleic Acid Amplification Techniques |
12 | Neoplasms |
12 | Nasopharynx |
12 | Nanoparticles |
12 | Mutagenesis |
12 | Molecular Dynamics Simulation |
12 | Molecular Docking Simulation |
12 | Microscopy, Electron, Transmission |
12 | Microbial Sensitivity Tests |
12 | Membrane Fusion |
12 | Mammals |
12 | Machine Learning |
12 | Lopinavir |
12 | Liver |
12 | Ions |
12 | Infectious Disease Transmission, Patient-to-Professional |
12 | Immunization, Passive |
12 | Hydrophobic and Hydrophilic Interactions |
12 | Histones |
12 | HLA-DR Antigens |
12 | Glycoproteins |
12 | France |
12 | Estrogen Receptor alpha |